|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
FY2020
12 months to Mar 31, 2020
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to net income (loss) to arrive at cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Amortization of deferred financing costs | |||||
| Impairment of goodwill and intangibles (Note 11) | |||||
| Impairment of long-lived assets | |||||
| Change in fair value of contingent consideration | |||||
| Impairment of held-for-sale assets | |||||
| Gain on sale of businesses (Note 7) | |||||
| Deferred income taxes | |||||
| Gain on foreign exchange | |||||
| Loss on disposal of property, plant, and equipment | |||||
| Loss on extinguishment of debt (Note 13) | |||||
| Share-based compensation | |||||
| Changes in assets and liabilities: | |||||
| Net receivables | |||||
| Net inventories | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued income taxes | |||||
| Federal excise, use, and other taxes | |||||
| Pension and other postretirement benefits | |||||
| Other assets and liabilities | |||||
| Cash provided by operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from note receivable | |||||
| Proceeds from the sale of businesses | |||||
| Acquisition of businesses, net of cash received | |||||
| Proceeds from the disposition of property, plant, and equipment | |||||
| Cash used for investing activities | |||||
| Financing Activities | |||||
| Proceeds from credit facility | |||||
| Repayments of credit facility | |||||
| Proceeds from issuance of long-term debt | |||||
| Payments on long-term debt | |||||
| Payments made for debt issue costs and prepayment premiums | |||||
| Early redemption of long-term debt | |||||
| Deferred payments for acquisitions | |||||
| Proceeds from exercise of stock options | |||||
| Payments made for contingent consideration | |||||
| Purchase of treasury shares | |||||
| Payment of employee taxes related to vested stock awards | |||||
| Cash (used for) provided by financing activities | |||||
| Effect of foreign currency exchange rate fluctuations on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Cash Flow Disclosures: | |||||
| Noncash investing activity: | |||||
| Capital expenditures included in accounts payable and other accrued liabilities | |||||
| Contingent consideration in connection with business combinations | |||||
Loading...